Target intelligence / Profile preview

Slit guidance ligand 1 (SLIT1)

Target
SLIT1
Molecular classification
Guidance cue, Secreted protein, Ligand (for Roundabout/ROBO receptors), Other (contains multiple EGF-like domains)
01

Overview

Slit guidance ligand 1 (SLIT1) is a secreted extracellular matrix protein that serves as a molecular guidance cue, primarily for axons and neural precursor cells in the central nervous system[1][2][3][4]. It binds to Roundabout (ROBO) family receptors, mediating repulsive signaling that directs axonal growth cones away from the midline during neural development and restricts inappropriate axon crossing. SLIT1 is also involved in regulating SVZ-derived precursor cell migration in adult neurogenesis and CNS repair, especially following injuries such as demyelination[2]. Loss of SLIT1 results in increased ectopic dispersal and recruitment of progenitor cells to lesion sites, but does not directly affect precursor proliferation or survival. SLIT1 is widely expressed in brain tissues, with a crucial role in neuron projection morphogenesis, chemorepulsion, and neurodevelopmental patterning[1][2][4]. Currently, SLIT1 has no approved interacting drugs, but its role in CNS repair makes it a potential therapeutic target under investigation for neurodegenerative and demyelinating diseases[2].

Other names
Slit homolog 1 proteinMEGF4SLIL1Slit-1KIAA0813Multiple EGF-like domains protein 4
02

Mechanism of action

If targeted, mechanisms would likely include modulation of neural precursor migration, axon guidance, CNS repair by altering the repulsive cues utilized for axonal or precursor cell positioning

03

Biological functions

Axon guidanceNeuronal migration and morphogenesisChemorepulsion in neurodevelopmentRegulation of adult neurogenesisRegulation of ectopic migration and recruitment of neural precursor cells (SVZ-NPCs), especially following central nervous system (CNS) demyelinationNegative regulation of inappropriate midline crossing by axons
04

Disease associations

Neurodegenerative disease (implicated in demyelinating conditions and CNS repair)Potential involvement in Amyotrophy, monomelic, and diaphragm diseaseOther (general nervous system developmental disorders)
05

Safety considerations

Manipulation of SLIT1 signaling could risk abnormal neural precursor migration, inappropriate axonal connections, or altered brain structure/functioncompensatory mechanisms by other Slit proteins may lessen impact

Beyond the preview

Go deeper on Slit guidance ligand 1 (SLIT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Slit guidance ligand 1 (SLIT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call